Newsroom
Advancing Brain Health: Insights from the NeuroForum on Epilepsy, Sleep Disorders, and the NeuroMatch Platform
Neurological health is the top cause of disability worldwide, but LVIS Corp is committed to revolutionizing diagnosis and treatment through cutting-edge neural information analysis technology. On June 28, 2024, our company’s recent NeuroForum served as an enlightening platform aimed at educating the public on epilepsy and sleep disorders—two critical areas of brain health that significantly ... Read more
LVIS NeuroMatch® Software Successfully Launched in 10 South Korean Hospitals
Over the years, researchers have made significant leaps in how we identify, treat, and manage neurological disorders – but in the past decade, these leaps have accelerated exponentially. At LVIS Corp, we’re driven by a passion for innovation and solving complex neurological challenges. Our team is in the midst of redefining the landscape of diagnosis ... Read more
LVIS Corporation Introduces NeuroMatch® at 2024 American Clinical Neurophysiology Society Meeting
LVIS Corporation, a leading innovator in healthcare technology, is pleased to announce its participation in the upcoming 2024 American Clinical Neurophysiology Society (ACNS) Meeting in Orlando, Florida, from February 29 to March 2, 2024.
